Catherine M. Burzik - 15 Oct 2023 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Interim CEO, Director
Signature
/s/ Geoffrey Gillespie, attorney-in-fact
Issuer symbol
OFIX
Transactions as of
15 Oct 2023
Net transactions value
$0
Form type
4
Filing time
17 Oct 2023, 17:14:24 UTC
Previous filing
21 Jun 2023
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +120,676 +318% $0.000000 158,625 15 Oct 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in full ninety (90) calendar days following the date that a successor Chief Executive Officer of Issuer assumes office following the Reporting Person's discontinuation of service as Interim Chief Executive Officer of Issuer.
F2 Includes 32,763 previously reported deferred stock units.